Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Rockwell Medical Inc is a drug manufacturers-specialty & generic business based in the US. Rockwell Medical shares (RMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Rockwell Medical employs 300 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $0.39 |
|---|---|
| 52-week range | $0.34 - $1.98 |
| 50-day moving average | $0.43 |
| 200-day moving average | $0.67 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.35 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.39 from 2022-01-26
| 1 week (2022-01-20) | -16.17% |
|---|---|
| 1 month (2021-12-23) | -2.50% |
| 3 months (2021-10-27) | -26.32% |
| 6 months (2021-07-27) | -45.83% |
| 1 year (2021-01-27) | -69.77% |
|---|---|
| 2 years (2020-01-27) | -85.50% |
| 3 years (2019-01-25) | 3.17 |
| 5 years (2017-01-27) | 5.61 |
| Revenue TTM | $61.8 million |
|---|---|
| Gross profit TTM | $2.7 million |
| Return on assets TTM | -26.1% |
| Return on equity TTM | -121.86% |
| Profit margin | -52.45% |
| Book value | $0.12 |
| Market capitalisation | $37.7 million |
TTM: trailing 12 months
We're not expecting Rockwell Medical to pay a dividend over the next 12 months.
Over the last 12 months, Rockwell Medical's shares have ranged in value from as little as $0.34 up to $1.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rockwell Medical's is 0.8728. This would suggest that Rockwell Medical's shares are less volatile than average (for this exchange).
Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Rockwell Medical, Inc.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.